Information & Newsletters


Subscribe to BAM’s general e-newsletter and learn about industry happenings, local life science news, and upcoming events. Want something a little more specific?  Want something extra? BAM's training e-newsletter gives you detailed information about upcoming conferences, events, and BAM training sessions. Plus, you'll find the occasional discount code from time-to-time. 


BAM Industry Report - 2017


Brief: In 2016 BAM conducted a study of the life sciences industry in Manitoba. We took care to measure all aspects of the industry in order to evaluate growth and contribution to the local economy.

BAM Real World Evidence Report - 2016

Brief: The 2016 BAM Real World Evidence Report is designed to highlight specific outcomes from the May 17, 2016 event. The report discusses data opportunities present in Manitoba, what makes Manitoba unique in the data space and the challenges and potential solutions relating to data are among the topics discussed in the report. The report concludes that Manitoba must understand, embrace and promote its data opportunity. 

BAM Industry Report - 2014

Brief: The 2014 BAM Industry Report is designed to profile Manitoba’s unique life science industry and to reveal the Industry’s successes, challenges and future direction. The report has compared findings with our 2012 study, as well as, two other national studies. Based on this study, we can conclude that Manitoba’s life science/bio-economy is strong and stable when compared to the rest of Canada.

BAM Patients as Partners Report

Brief: Healthcare occupies a unique position in the lives of Canadians. Not only is it an issue of great personal importance to families, but it has been, and likely always will be, of great significance to elected policy makers. Our health care system plays an important role in our identity as Canadians.

BAM SEB Forum Report

Brief: Canada’s public health care system faces many challenges to evolve as we move further into the twenty first century. Ageing populations with increasing service expectations offer a challenge to the system from one side, while relentless medical innovation offers exciting opportunities from another side. Some of these opportunities can come with a high cost, while offering significant benefits to patients. The area of public health care policy that perhaps captures these broad dual pressures more than any other is pharmacy and the provincial systems of publicly-funded provision of medication for Canadians. 

BAM Diabetes Forum Report

Brief: Manitoba is faced with profound health and socio-economic issues directly related to diabetes. While all demographic groups in the province are affected, indigenous populations in the northern region have reported a significantly higher incidence of Type 2 diabetes when compared to the national average. In one study examining the incidence for Type 2 diabetes in children alone, the rates in Manitoba were nearly ten times higher than those in other provinces.